ImpactRx announced today that Ewa J. Kleczyk, PhD, Senior Director, Consulting Analytics, was honored as an industry Rising Star by the Healthcare Businesswomen's Association (HBA).
ImpactRx, the pioneer in measuring the impact of promotion on physicians' attitudes and prescribing behavior, announced today the launch of a voice capture response enhancement to their unique POP 2.0™ research tool.
Senior management team strengthened as Former Symphony Services executive brings his operations and technology experience and expertise to new leadership role.
ImpactRx, a Symphony Technology Group (STG) company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies, in order to combine the highly complementary capabilities of the two companies.
ImpactRx measures the impact of promotion on physician prescribing behavior. Patients request more than 250,000 brand annually, ImpactRx then records physician's treatment behavior in response to their request.
ImpactRx expanded its psychiatry research panel to better serve the growing neruoscience category, in particular ADD/ADHD market. Psychiatrists are evaluating and reporting prescribing behavior. iPhone-connected psychiatrists capture feedback in real time.
Satisfied Users & 
Approved Press Releases
